{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T18:40:36Z","timestamp":1770144036449,"version":"3.49.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018568","name":"Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018568","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key Areas of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116930","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T20:23:34Z","timestamp":1728505414000},"page":"116930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Development of selective heterocyclic PDE4 inhibitors for treatment of psoriasis"],"prefix":"10.1016","volume":"280","author":[{"given":"Gang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengqin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xudong","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanghui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zichen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Qiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siying","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengming","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2024.116930_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejmech.2024.116930_bib2","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ejmech.2024.116930_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2024.116930_bib4","first-page":"s216","article-title":"Psoriasis and psoriatic arthritis overview","volume":"22","author":"Menter","year":"2016","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ejmech.2024.116930_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2014.01.008","article-title":"Diagnosis and classification of psoriasis","volume":"13","author":"Raychaudhuri","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.ejmech.2024.116930_bib6","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nri3707","article-title":"The IL-23\u2013IL-17 immune Axis: from mechanisms to therapeutic testing","volume":"14","author":"Gaffen","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejmech.2024.116930_bib7","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1021\/acs.jmedchem.1c02058","article-title":"Discovery and structural optimization of toddacoumalone derivatives as novel PDE4 inhibitors for the topical treatment of psoriasis","volume":"65","author":"Song","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib8","first-page":"428","article-title":"Calcitriol 3 microg\/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies","volume":"6","author":"Lebwohl","year":"2007","journal-title":"J. Drugs Dermatol. JDD : J. Drugs Dermatol. JDD"},{"key":"10.1016\/j.ejmech.2024.116930_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/09546634.2017.1395796","article-title":"Review of IL-17 inhibitors for psoriasis","volume":"29","author":"Amin","year":"2018","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.ejmech.2024.116930_bib10","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.4049\/jimmunol.1800013","article-title":"Discovery of the IL-23\/IL-17 signaling pathway and the treatment of psoriasis","volume":"201","author":"Hawkes","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2024.116930_bib11","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/jdv.18042","article-title":"Anti-drug antibodies of IL-23 inhibitors for psoriasis: a systematic review","volume":"36","author":"Norden","year":"2022","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ejmech.2024.116930_bib12","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12946","article-title":"The TNF\/IL-23\/IL-17 axis-head-to-head trials comparing different biologics in psoriasis treatment","volume":"92","author":"Ten Bergen","year":"2020","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.ejmech.2024.116930_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.12788\/j.sder.2018.039","article-title":"TNF inhibitors for psoriasis","volume":"37","author":"Chima","year":"2018","journal-title":"Semin. Cutan. Med. Surg."},{"key":"10.1016\/j.ejmech.2024.116930_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/1744666X.2020.1771182","article-title":"TNF-\u0391 inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis","volume":"16","author":"Gisondi","year":"2020","journal-title":"Expet Rev. Clin. Immunol."},{"key":"10.1016\/j.ejmech.2024.116930_bib15","first-page":"21","volume":"vol. 11","author":"Milakovic","year":"2021"},{"key":"10.1016\/j.ejmech.2024.116930_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s13555-019-00347-w","article-title":"Systemic treatment of psoriasis with jak inhibitors: a review","volume":"10","author":"Kvist-Hansen","year":"2020","journal-title":"Dermatology and therapy"},{"key":"10.1016\/j.ejmech.2024.116930_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2022.2154122","article-title":"Deucravacitinib in the treatment of psoriasis","volume":"34","author":"Estevinho","year":"2023","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.ejmech.2024.116930_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.apsb.2019.11.006","article-title":"A novel S1P1 modulator IMMH002 ameliorates psoriasis in multiple animal models","volume":"10","author":"Jin","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2024.116930_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/jid.2010.255","article-title":"Stat3 as A Therapeutic target for the treatment of psoriasis: a clinical feasibility study with STA-21, A Stat3 inhibitor","volume":"131","author":"Miyoshi","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejmech.2024.116930_bib20","article-title":"Targeting Nrf2 with 3 H-1,2-dithiole-3-thione to moderate OXPHOS-driven oxidative stress attenuates IL-17A-induced psoriasis","volume":"159","author":"Liu","year":"2023","journal-title":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie"},{"key":"10.1016\/j.ejmech.2024.116930_bib21","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.3390\/ijms23084433","article-title":"1,5-Disubstituted acylated 2-Amino-4,5-dihydroimidazoles as a new class of retinoic acid receptor-related orphan receptor (ROR) inhibitors","volume":"23","author":"Ortiz","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116930_bib22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2024.116930_bib23","doi-asserted-by":"crossref","first-page":"10594","DOI":"10.1021\/acs.jmedchem.9b02170","article-title":"Advances in the development of phosphodiesterase-4 inhibitors","volume":"63","author":"Peng","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib24","doi-asserted-by":"crossref","first-page":"8052","DOI":"10.3390\/ijms25158052","article-title":"PDE4D: a multipurpose pharmacological target","volume":"25","author":"Lusardi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2024.116930_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115195","article-title":"Advances in the development of phosphodiesterase-4 inhibitors","volume":"250","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib26","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jaad.2023.11.005","article-title":"Orismilast in moderate-to-severe psoriasis: efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)","volume":"90","author":"Warren","year":"2024","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ejmech.2024.116930_bib27","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1007\/s13555-023-01054-3","article-title":"Next generation PDE4 inhibitors that selectively target PDE4B\/D subtypes: a narrative review","volume":"13","author":"Blauvelt","year":"2023","journal-title":"Dermatology and therapy"},{"key":"10.1016\/j.ejmech.2024.116930_bib28","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1021\/acs.jmedchem.9b00518","article-title":"Structure-aided identification and optimization of tetrahydro-isoquinolines as novel PDE4 inhibitors leading to discovery of an effective antipsoriasis agent","volume":"62","author":"Zhang","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113004","article-title":"Design, synthesis, and biological evaluation of tetrahydroisoquinolines derivatives as novel, selective PDE4 inhibitors for antipsoriasis treatment","volume":"211","author":"Zhang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113171","article-title":"Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis","volume":"213","author":"Chu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib31","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.2174\/1568026621666210527103225","article-title":"Imidazole scaffold based compounds in the development of therapeutic drugs","volume":"21","author":"Hu","year":"2021","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib32","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/1389557517666170228113656","article-title":"Imidazole: an essential edifice for the identification of new lead compounds and drug development","volume":"18","author":"Shalmali","year":"2018","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib33","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.ejmech.2017.12.044","article-title":"Recent advance in oxazole-based medicinal chemistry","volume":"144","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib34","doi-asserted-by":"crossref","first-page":"7337","DOI":"10.2174\/0929867326666181203130402","article-title":"Oxazole-based compounds as anticancer agents","volume":"26","author":"Chiacchio","year":"2019","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib35","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","article-title":"Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice","volume":"53","author":"Gao","year":"2020","journal-title":"Biol. Res."},{"key":"10.1016\/j.ejmech.2024.116930_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109615","article-title":"Convallatoxin induces HaCaT cell necroptosis and ameliorates skin lesions in psoriasis-like mouse models","volume":"121","author":"Jiang","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116930_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112229","article-title":"Anti-psoriatic and anti-inflammatory effects of kaempferia parviflora in keratinocytes and macrophage cells","volume":"143","author":"Takuathung","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116930_bib38","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2024.116930_bib39","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","article-title":"Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function","volume":"19","author":"Morris","year":"1998","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2024.116930_bib40","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1021\/acs.biochem.8b00336","article-title":"Identification of a PDE4-specific pocket for the design of selective inhibitors","volume":"57","author":"Feng","year":"2018","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2024.116930_bib41","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ejps.2017.03.024","article-title":"Cumulative evidence of the low reliability of frozen\/thawed pig skin as A model for in vitro percutaneous permeation testing","volume":"102","author":"Sintov","year":"2017","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2024.116930_bib42","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 Axis1","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2024.116930_bib43","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jconrel.2022.08.038","article-title":"Sonodynamic therapy by phase-transition nanodroplets for reducing epidermal hyperplasia in psoriasis","volume":"350","author":"Xi","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejmech.2024.116930_bib44","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1038\/s41467-024-49577-3","article-title":"Sensory ASIC3 channel exacerbates psoriatic inflammation via a neurogenic pathway in female mice","volume":"15","author":"Huang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2024.116930_bib45","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jaci.2019.10.041","article-title":"Short-term transcriptional response to IL-17 receptor-A antagonism in the treatment of psoriasis","volume":"145","author":"Tomalin","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejmech.2024.116930_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115412","article-title":"Design, synthesis and anti-inflammatory activity study of lansiumamide analogues for treatment of acute lung injury","volume":"166","author":"Song","year":"2023","journal-title":"Biomed. Pharmacother."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T06:22:25Z","timestamp":1732170145000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424008110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":46,"alternative-id":["S0223523424008110"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116930","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of selective heterocyclic PDE4 inhibitors for treatment of psoriasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116930"}}